Devices and methods for molecular diagnostic testing

Inventors

Andreyev, Boris • Moravick, Keith E. • Ciopyk, Brian • Briones, Victor • Loney, Gregory • De La Zerda, Adam • Ching, Jesus • Chu, Steven • Swenson, David • Huang, Helen • Kelly, Colin

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Assignees

Visby Medical Inc

Member
Visby Medical
Visby Medical

Visby Medical develops rapid at-home molecular diagnostic tests powered by polymerase chain reaction (PCR) technology, focusing on accessible, private, and accurate screening for sexually transmitted infections (STIs). The company offers the first FDA-authorized over-the-counter at-home PCR test for women’s sexual health and is expanding its diagnostics platform to address other infectious diseases for point-of-care and home use. Its technology enables results in approximately 30 minutes via a secure mobile app, with integrated telehealth services for positive results. Visby Medical emphasizes user privacy, scalable manufacturing, and partnerships to broaden access to high-quality diagnostics.

Publication Number

US-12138624-B2

Patent

Publication Date

2024-11-12

Expiration Date


Abstract

A hand-held molecular diagnostic test device includes a housing, an amplification (or PCR) module, and a detection module. The amplification module is configured to receive an input sample, and defines a reaction volume. The amplification module includes a heater such that the amplification module can perform a polymerase chain reaction (PCR) on the input sample. The detection module is configured to receive an output from the amplification module and a reagent formulated to produce a signal that indicates a presence of a target amplicon within the input sample. The amplification module and the detection module are integrated within the housing.

Core Innovation

The invention relates to a stand-alone molecular diagnostic test device used to detect a target nucleic acid within a biological sample at a decentralized location without using any external instrument to amplify the target nucleic acid and react each of the target amplicon and the reagent. The device is coupled to a power source and includes a flow path with a sample input opening, a reaction volume, and a detection volume, together with a control module, a fluid pump, and a heater. The device actuates itself by providing power to the heater and the fluid pump under control of the control module.

During actuation, the fluid pump produces a flow rate of the biological sample within the flow path by moving a movable member in a first direction. The control module regulates heater power based on a temperature set point so that the heater amplifies the target nucleic acid within the reaction volume to produce a target amplicon. The device then moves the movable member in a second direction to produce a flow of a reagent within the detection volume, where the reagent is formulated to produce a signal indicating a presence of the target amplicon.

The detection is performed by reacting, within the detection volume, each of the target amplicon and the reagent and reading a result associated with the signal. In the stand-alone decentralized operation, the flow path, the control module, the fluid pump, and the heater are contained within a housing, and the result is read from an outer surface of the housing. The claims further support implementations where the heater and reaction flow path provide thermally cycling amplification by using a serpentine reaction flow path and a heater having first and second heating portions that create first and second temperature zones.

Claims Coverage

The provided material includes two independent claims. Each independent claim is grounded in a stand-alone, decentralized molecular diagnostic approach that integrates power-coupled fluid pumping, heater-based amplification, reagent delivery into a detection volume, and signal-based result reading without external amplification or external reaction instrumentation. Across the independent claims, the inventive features collectively define (i) device self-actuation with pump/heater control, (ii) in-device amplification and reagent reaction, and (iii) housing-contained operation with result readout and discarding.

Stand-alone amplification and reagent reaction controlled within the device

A stand-alone molecular diagnostic test device that does not use any external instrument to amplify the target nucleic acid and react each of the target amplicon and the reagent.

Pump-driven sample and reagent flow with control module regulation

The control module regulates power to the fluid pump to move a movable member in a first direction to produce a flow rate of the biological sample within the flow path, and then moves the movable member in a second direction to produce a flow of a reagent within the detection volume.

Heater power regulation based on a temperature set point for amplification

The control module regulates power from the power source to the heater based on a temperature set point to amplify, within the reaction volume, the target nucleic acid to produce a target amplicon.

Signal generation in a detection volume followed by reading a result

The reagent formulated to produce a signal indicating a presence of the target amplicon is reacted with the target amplicon within the detection volume, and a result associated with the signal is read.

Decentralized location access with housing-contained components and discard

Accessing at a decentralized location the molecular diagnostic test device in which the flow path, control module, fluid pump, and heater are contained within a housing; reading the result from an outer surface of the housing and discarding the molecular diagnostic test device after the reading.

Across the independent claims, the coverage centers on a stand-alone, decentralized molecular diagnostic test device that self-manages fluid flow (sample and reagent) and heater-based amplification within in-device reaction and detection volumes, generates a signal from a reagent reaction with the target amplicon, reads a result from the housing, and does not rely on any external instrument for amplification and reaction.

Stated Advantages

Stand-alone operation that does not use any external instrument to amplify the target nucleic acid and react each of the target amplicon and the reagent.

A result is read from an outer surface of the housing after internal amplification and reaction.

After the reading, the molecular diagnostic test device is discarded.

Documented Applications

Decentralized location access for detecting a target nucleic acid within a biological sample using a stand-alone molecular diagnostic test device.

Detecting a target nucleic acid using a method performed with a molecular diagnostic test device coupled to a power source and employing internal amplification and internal reagent reaction followed by reading a result.

Detection of a target nucleic acid within a biological sample using a molecular diagnostic test device accessed at a decentralized location, followed by reading a result from an outer surface of the housing and discarding the device after the reading.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.